S87694 |
CL2A-SN-38 |
源叶(MedMol) | 98% |
- 产品描述: CL2A-SN-38 is a agent-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody agent conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A-SN-38 uses hydrolyzable linker to deliver active agents within tumor cells and in the tumor microenvironment, resulting in bystander effects
- 靶点: Camptothecins
- 体内研究:
CL2A-SN-38 偶联抗 Trop-2 人源化抗体 hRS7 (腹腔注射,0.2或0.4mg/kg,每周2次,4周) 均能显著抑制人结肠 (COLO 205) 或胰腺小鼠肿瘤异种移植物模型的肿瘤生长 (Capan-1)
- 参考文献:
1. Cardillo TM, et al. Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. Clin Cancer Res. 2011 May 15;17(10):3157-69. 2. Thomas M Cardillo, et al. Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. Clin Cancer Res. 2011 May 15;17(10):3157-69.
- 溶解性: Soluble in DMSO
- 保存条件: -20°C
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 0.676 ml 3.379 ml 6.758 ml 5 mM 0.135 ml 0.676 ml 1.352 ml 10 mM 0.068 ml 0.338 ml 0.676 ml 50 mM 0.014 ml 0.068 ml 0.135 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)